The Mexican consensus on nonalcoholic fatty liver disease

被引：41

作者：

Bernal-Reyes, R. ^{[1
]}

Castro-Narro, G. ^{[2
]}

Male-Velazquez, R. ^{[3
]}

Carmona-Sanchez, R. ^{[4
]}

Gonzalez-Huezo, M. S. ^{[5
]}

Garcia-Juarez, I. ^{[2
]}

Chavez-Tapia, N. ^{[6
]}

Aguilar-Salinas, C. ^{[7
]}

Aiza-Haddad, I. ^{[8
]}

Ballesteros-Amozurrutia, M. A. ^{[9
]}

Bosques-Padilla, F. ^{[10
]}

Castillo-Barradas, M. ^{[11
]}

Chavez-Barrera, J. A. ^{[12
]}

Cisneros-Garza, L. ^{[13
]}

Flores-Calderon, J. ^{[14
]}

Garcia-Compean, D. ^{[13
]}

Gutierrez-Grobe, Y. ^{[6
]}

Higuera de la Tijera, M. F. ^{[15
]}

Kershenobich-Stalnikowitz, D. ^{[7
]}

Ladron de Guevara-Cetina, L. ^{[16
]}

Lizardi-Cervera, J. ^{[6
]}

Lopez-Cossio, J. A. ^{[5
]}

Martinez-Vazquez, S. ^{[2
]}

Marquez-Guillen, E. ^{[7
]}

Mendez-Sanchez, N. ^{[6
]}

Moreno-Alcantar, R. ^{[17
]}

Poo-Ramirez, J. L. ^{[18
]}

Ramos-Martinez, P. ^{[19
]}

Rodriguez-Hernandez, H. ^{[20
]}

Sanchez-Avila, J. F. ^{[21
]}

Stoopen-Rometti, M. ^{[22
]}

Torre-Delgadillo, A. ^{[2
]}

Torres-Villalobos, G. ^{[7
]}

Trejo-Estrada, R. ^{[23
]}

Uribe-Esquivel, M. ^{[6
]}

Velarde-Ruiz Valazco, J. A. ^{[24
]}

机构：

[1] Soc Espanola Beneficencia, Pachuca, Hidalgo, Mexico

[2] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Gastroenterol, Mexico City, DF, Mexico

[3] Inst Salud Digest & Hepat SA CV, Guadalajara, Jalisco, Mexico

[4] Consulta Privada, San Luis Potosi, Mexico

[5] ISSSEMYM, Serv Gastroenterol & Endoscopia GI, Metepec, Estado De Mexic, Mexico

[6] Fdn Clin Med Sur, Serv Gastroenterol, Mexico City, DF, Mexico

[7] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico

[8] Hosp Angeles Lomas, Clin Enfermedades Hepat, Mexico City, DF, Mexico

[9] Hosp Angeles Pedregal, Mexico City, DF, Mexico

[10] Ctr Med Zambrano Hell, Monterrey, Nuevo Leon, Mexico

[11] Hosp Especialidades Ctr Med La Raza, Ctr Med La Raza IMSS, Serv Gastroenterol, Mexico City, DF, Mexico

[12] IMSS, Ctr Med La Raza, Serv Gastroenterol Pediat, Hosp Gen, Mexico City, DF, Mexico

[13] Hosp Univ UANL, Serv Gastroenterol, Monterrey, Nuevo Leon, Mexico

[14] IMSS, Ctr Med Siglo 21, Hosp Pediat, Serv Gastroenterol, Mexico City, DF, Mexico

[15] Hosp Gen Mexico City, Serv Gastroenterol, Mexico City, DF, Mexico

[16] Hosp Angeles Clin Londres, Mexico City, DF, Mexico

[17] Hosp Especialidades Ctr Med La Raza, Ctr Med Siglo 21, IMSS, Serv Gastroenterol, Mexico City, DF, Mexico

[18] Tec Monterrey, Ctr Innovac & Educ Ejecut, Mexico City, DF, Mexico

[19] Ctr Patol Especializada SLP, San Luis Potosi, Mexico

[20] Hosp Especialidades Ctr Med La Raza, United Invest Biomed AMCCI, Durango, Mexico

[21] Tecnol Monterrey, Escuela Med & Ciencias Salud, Monterrey, Nuevo Leon, Mexico

[22] Ctr Diagnost CT Scanner Lomas Altas, Mexico City, DF, Mexico

[23] Ctr Med ABC, Mexico City, DF, Mexico

[24] Hosp Civil Guadalajara, Dept Gastroenterol, Guadalajara, Jalisco, Mexico

来源：

REVISTA DE GASTROENTEROLOGIA DE MEXICO | 2019年 / 84卷 / 01期

关键词：

Nonalcoholic fatty liver disease; Mexican consensus; CONTROLLED TRANSIENT ELASTOGRAPHY; INTRAHEPATIC LIPID-CONTENT; PLACEBO-CONTROLLED TRIAL; MAGNETIC-RESONANCE ELASTOGRAPHY; HEPATOCELLULAR-CARCINOMA HCC; DE-NOVO LIPOGENESIS; LONG-TERM OUTCOMES; VITAMIN-E; CRYPTOGENIC CIRRHOSIS; INSULIN-RESISTANCE;

D O I：

10.1016/j.rgmx.2018.11.007

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Nonalcoholic fatty liver disease (NAFLD) affects nearly one third of the population worldwide. Mexico is one of the countries whose population has several risk factors for the disease and its prevalence could surpass 50%. If immediate action is not taken to counteract what is now considered a national health problem, the medium-term panorama will be very bleak. This serious situation prompted the Asociacion Mexicana de Gastroenterologia and the Asociacion Mexicana de Hepatologia to produce the Mexican Consensus on Fatty Liver Disease. It is an up-to-date and detailed review of the epidemiology, pathaphysialogy, clinical forms, diagnosis, and treatment of the disease, whose aim is to provide the Mexican physician with a useful tool for the prevention and management of nonalcoholic fatty Liver disease. (C) 2019 Asociacion Mexicana de Gastroenterologia. Published by Masson Doyma Mexico S.A.

引用

页码：69 / 99

页数：31

共 297 条

[51] Nonalcoholic steatohepatitis: the new frontier for liver transplantation [J].

Bzowej, Natalie H. .

CURRENT OPINION IN ORGAN TRANSPLANTATION, 2018, 23 (02) :169-174

[52] Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease [J].

Caldwell, SH ;

Oelsner, DH ;

Iezzoni, JC ;

Hespenheide, EE ;

Battle, EH ;

Driscoll, CJ .

HEPATOLOGY, 1999, 29 (03) :664-669

[53] The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease [J].

Caldwell, SH ;

Crespo, DM .

JOURNAL OF HEPATOLOGY, 2004, 40 (04) :578-584

[54] NASH and cryptogenic cirrhosis: A histological analysis [J].

Caldwell, Stephen H. ;

Lee, Vanessa D. ;

Kleiner, David E. ;

Al-Osaimi, Abdullah M. S. ;

Argo, Curtis K. ;

Northup, Patrick G. ;

Berg, Carl L. .

ANNALS OF HEPATOLOGY, 2009, 8 (04) :346-352

[55] Comparison of blood tests for liver fibrosis specific or not to NAFLD [J].

Cales, Paul ;

Laine, Fabrice ;

Boursier, Jerome ;

Deugnier, Yves ;

Moal, Valerie ;

Oberti, Frederic ;

Hunault, Gilles ;

Rousselet, Marie Christine ;

Hubert, Isabelle ;

Laafi, Jihane ;

Ducluzeaux, Pierre Henri ;

Lunel, Francoise .

JOURNAL OF HEPATOLOGY, 2009, 50 (01) :165-173

[56] Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study [J].

Capanni, M ;

Calella, F ;

Biagini, MR ;

Genise, S ;

Raimondi, L ;

Bedogni, G ;

Svegliati-Baroni, G ;

Sofi, F ;

Milani, S ;

Abbate, R ;

Surrenti, C ;

Casini, A .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (08) :1143-1151

[57]

Carriedo AP, 2013, NUTR HOSP, V28, P357

[58] Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation [J].

Carter, Danielle ;

Dieterich, Douglas T. ;

Chang, Charissa .

CLINICS IN LIVER DISEASE, 2018, 22 (01) :213-+

[59] Pain experienced during percutaneous liver biopsy [J].

Castéra, L ;

Nègre, I ;

Samii, K ;

Buffet, C .

HEPATOLOGY, 1999, 30 (06) :1529-1530

[60] Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Non-invasive tests are enough [J].

Castera, Laurent .

LIVER INTERNATIONAL, 2018, 38 :67-70

← 1 2 3 4 5 6 7 8 9 10 →